A Novel Anti-Thrombotic, Glenzocimab, in Covid-19 acute respiratory distress syndrome (Cov-ARDS).

J. Pottecher (Strasbourg, France), V. Sato (Sau Paulo, Brazil), Y. Plétan (Paris, France), A. Comenducci (Paris, France), V. Desort-Henin (paris, France), M. Jandrot-Perrus (Paris, France), S. Binay (Paris, France), A. Meilhoc (Paris, France), G. Avenard (Paris, France)

Source: International Congress 2022 – COVID-19 acute respiratory distress syndrome and beyond

Session: COVID-19 acute respiratory distress syndrome and beyond
Session type: Oral Presentation
Number: 2310

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Pottecher (Strasbourg, France), V. Sato (Sau Paulo, Brazil), Y. Plétan (Paris, France), A. Comenducci (Paris, France), V. Desort-Henin (paris, France), M. Jandrot-Perrus (Paris, France), S. Binay (Paris, France), A. Meilhoc (Paris, France), G. Avenard (Paris, France). A Novel Anti-Thrombotic, Glenzocimab, in Covid-19 acute respiratory distress syndrome (Cov-ARDS).. 2310

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.